Head-to-head · Cost-Efficiency Index
RxION Health vs Tablet Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
RxION Health
Cost-first shoppers who want a flat, dose-independent monthly price with no titration surcharges, outside NJ/AK/MS.
Visit RxION HealthTablet Health
Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list.
Visit Tablet HealthThe verdict
RxION Health and Tablet Health tie on the Cost-Efficiency Index at 57/100, so neither wins outright on the numbers. For most shoppers we'd start with RxION Health (ranked #311, a hair above #315) — Cost-first shoppers who want a flat, dose-independent monthly price with no titration surcharges, outside NJ/AK/MS. But Tablet Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs RxION Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | RxION Health | Tablet Health |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 57/100 |
| Semaglutide / mo | $99/mo (all doses, plus a separate fee, compounded) | $199/mo (compounded) |
| Tirzepatide / mo | $183/mo (all doses, compounded) | $299/mo (compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,388 |
| Tirzepatide / yr (modeled) | $2,196 | $3,588 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #311 | #315 |
RxION Health
57/100Where the value is
- One flat monthly price regardless of dose — no per-mg price ladder to climb as you titrate up
- Free cold-pack overnight shipping and injection supplies stated as included on both drug pages
- LegitScript Certified badge displayed and independently verifiable
The tradeoffs
- The displayed $99/$183 prices sit against a struck-through $199/$299 'regular' price with no stated end date — it is unclear whether this is a permanent or temporary rate
- Not available to residents of New Jersey, Alaska, or Mississippi
Tablet Health
57/100Where the value is
- LegitScript Certified — seal displayed on the site
- Offers both oral-tablet and injectable forms of semaglutide AND tirzepatide, four distinct SKUs
- Published per-product pricing rather than a single vague 'starting at' figure: $179-$299/mo across the four variants
The tradeoffs
- States served are not published anywhere on the accessible site — eligibility is only revealed by completing the intake quiz
- The homepage's 'Flat monthly pricing starting at $149' banner cannot be tied to any of the four listed $179-$299 tiers
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.